Celularity CELU Cash Flow Statement (2019-2025)

NASDAQ CELU
$1.43 -0.01 (-0.69%)
As of: Sep 10, 2026 · 2:25 PM EDT
Reported Financials

Celularity Quarterly Cash Flow Statement

Periods 28 quarters
Latest Dec 2025

Celularity reported cash from operations of -$5.10M and free cash flow of -$5.10M for the quarter ended Dec 2025, down 420.1% year over year. This cash flow statement covers 28 quarters of results from Mar 2019 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income
-81.50M-64.52M49.94M-4.04M-62.87M47.83M4.80M24.43M-64.02M-47.95M-93.88M9.55M-22.01M-6.49M-16.10M-1.14M-19.75M-24.52M-23.08M-24.36M
Share-based CompensationStock Comp.
1.01M28.19M8.88M1.93M2.42M4.53M4.52M4.39M3.99M3.86M3.58M2.97M2.99M2.67M2.94M2.64M0.11M0.47M3.25M
Deferred Taxes
-0.04M-1.31M0.00M
Gains from Investment SecuritiesGains Investment
36.51M1.17M-39.94M-23.30M20.93M-43.21M-9.33M-52.84M-18.93M0.13M-5.19M8.88M-7.00M-0.71M-1.55M-0.24M1.28M4.26M-1.98M
Asset Writedowns and ImpairmentWritedown
-0.06M0.17M-0.00M0.18M0.23M-0.23M0.98M0.90M0.61M107.19M0.20M0.10M-0.08M0.23M-0.06M0.01M-0.10M3.04M
Cash from OperationsCash from Ops.
-25.08M-18.20M-34.77M-32.05M-34.25M-36.32M-37.72M-29.59M-14.99M-11.03M-8.32M-4.34M-4.40M-3.45M-0.14M1.59M-2.99M-1.00M-4.16M-5.10M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
1.94M1.93M2.34M2.61M2.28M2.32M2.39M2.44M2.36M2.32M2.34M2.30M2.16M2.00M1.89M1.88M1.83M1.83M1.82M1.80M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.18M0.10M0.84M1.16M1.11M0.08M1.50M0.90M-0.79M-0.47M1.38M6.71M3.92M-0.19M-4.79M5.02M1.35M-3.81M-4.54M-0.55M
Change in InventoryChange Inventory
1.16M0.53M2.09M2.64M5.67M9.02M2.14M0.06M1.81M1.01M-1.22M-0.74M-3.18M-1.97M-0.50M-0.63M-2.55M-3.66M-2.31M-1.73M
Change in Account PayablesChange Payables
0.09M1.55M-0.27M1.64M1.33M-0.31M-0.72M-3.25M2.73M3.31M0.71M1.74M-1.17M0.78M1.71M7.93M0.02M1.09M0.19M1.83M
Change in Accured ExpensesChange Accured Exp.
-1.27M2.50M2.62M-5.65M0.60M5.15M0.80M-9.17M0.73M-0.08M0.89M-2.66M1.17M1.99M4.08M5.40M2.71M6.23M0.82M3.69M
Change in TaxesChange Taxes
Other Working Capital ChangesOther WC Changes
-0.60M-2.45M-5.58M6.01M-0.10M0.31M1.22M-1.01M-0.27M-0.60M-1.14M-2.15M-0.18M0.47M0.03M-0.61M0.03M0.09M-0.91M-0.29M
Investing Activities
Capital ExpendituresCapex
1.48M1.31M1.11M2.30M1.45M1.44M1.56M0.78M0.70M0.31M-0.26M0.30M0.04M0.03M1.43M
Cash from Investing ActivitiesCash from Investing
-1.48M-1.01M-1.11M-2.30M-1.45M-1.44M-1.56M-0.78M-3.21M-0.03M-0.23M-0.58M-0.04M2.14M-1.59M
Financing Activities
Other financing activitiesOther financing
83.39M46.48M0.00M0.00M-16.49M9.00M3.75M6.00M-5.94M1.45M-2.35M
Cash from Financing ActivitiesCash from Financing
-4.84M4.01M100.40M-1.01M46.49M27.72M43.94M1.69M12.76M5.61M5.74M-0.01M6.23M-0.09M-0.08M0.64M2.32M1.63M3.48M11.22M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
2.46M-1.43M
Additional items
Change in Cash
-31.40M-15.19M64.52M-35.36M10.79M-10.04M4.66M-28.68M-5.45M-5.45M-2.81M-4.93M1.78M-1.39M-0.22M0.65M-0.67M0.63M-0.68M6.12M
Free Cash FlowFCF
-26.56M-19.51M-35.88M-34.35M-35.71M-37.76M-39.28M-30.36M-15.69M-11.34M-8.06M-4.64M-4.44M-3.48M-0.14M0.16M-2.99M-1.00M-4.16M-5.10M
Net Cash FlowNCF
-31.40M-15.19M64.52M-35.36M10.79M-10.04M4.66M-28.68M-5.45M-5.45M-2.81M-4.93M1.78M-1.39M-0.22M0.65M-0.67M0.63M-0.68M6.12M